|
asx:vti
|
10193401
|
Apr 14th, 2024 12:00AM
|
Visioneering Technologies Inc.
|
1.2K
|
29.00
|
Open
|
|
Apr 14th, 2024 07:26AM
|
Apr 14th, 2024 07:26AM
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories, with an additional eight patents pending.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
|
Open
|
Multifocal Contact Lenses
|
Open
|
10745 Westside Way
|
Alpharetta
|
Georgia
|
US
|
30009
|
|
Visioneering Technologies
|
|
|
|
asx:vti
|
10193401
|
Apr 13th, 2024 12:00AM
|
Visioneering Technologies Inc.
|
1.2K
|
29.00
|
Open
|
|
Apr 13th, 2024 06:18AM
|
Apr 13th, 2024 06:19PM
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories, with an additional eight patents pending.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
|
Open
|
Multifocal Contact Lenses
|
Open
|
10745 Westside Way
|
Alpharetta
|
Georgia
|
US
|
30009
|
|
Visioneering Technologies
|
|
|
|
asx:vti
|
10193401
|
Apr 12th, 2024 12:00AM
|
Visioneering Technologies Inc.
|
1.2K
|
29.00
|
Open
|
|
Apr 12th, 2024 06:33AM
|
Apr 12th, 2024 03:30PM
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories, with an additional eight patents pending.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
|
Open
|
Multifocal Contact Lenses
|
Open
|
10745 Westside Way
|
Alpharetta
|
Georgia
|
US
|
30009
|
|
Visioneering Technologies
|
|
|
|
asx:vti
|
10193401
|
Apr 11th, 2024 12:00AM
|
Visioneering Technologies Inc.
|
1.2K
|
29.00
|
Open
|
|
Apr 11th, 2024 08:37AM
|
Apr 11th, 2024 06:35PM
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories, with an additional eight patents pending.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
|
Open
|
Multifocal Contact Lenses
|
Open
|
10745 Westside Way
|
Alpharetta
|
Georgia
|
US
|
30009
|
|
Visioneering Technologies
|
|
|
|
asx:vti
|
10193401
|
Apr 10th, 2024 12:00AM
|
Visioneering Technologies Inc.
|
1.2K
|
29.00
|
Open
|
|
Apr 10th, 2024 06:19AM
|
Apr 11th, 2024 02:25AM
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories, with an additional eight patents pending.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
|
Open
|
Multifocal Contact Lenses
|
Open
|
10745 Westside Way
|
Alpharetta
|
Georgia
|
US
|
30009
|
|
Visioneering Technologies
|
|
|
|
asx:vti
|
10193401
|
Apr 9th, 2024 12:00AM
|
Visioneering Technologies Inc.
|
1.2K
|
29.00
|
Open
|
|
Apr 9th, 2024 06:42AM
|
Apr 9th, 2024 04:51PM
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories, with an additional eight patents pending.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
|
Open
|
Multifocal Contact Lenses
|
Open
|
10745 Westside Way
|
Alpharetta
|
Georgia
|
US
|
30009
|
|
Visioneering Technologies
|
|
|
|
asx:vti
|
10193401
|
Apr 8th, 2024 12:00AM
|
Visioneering Technologies Inc.
|
1.2K
|
29.00
|
Open
|
|
Apr 8th, 2024 07:14AM
|
Apr 8th, 2024 07:14AM
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories, with an additional eight patents pending.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
|
Open
|
Multifocal Contact Lenses
|
Open
|
10745 Westside Way
|
Alpharetta
|
Georgia
|
US
|
30009
|
|
Visioneering Technologies
|
|
|
|
asx:vti
|
10193401
|
Apr 7th, 2024 12:00AM
|
Visioneering Technologies Inc.
|
1.2K
|
29.00
|
Open
|
|
Apr 7th, 2024 06:48AM
|
Apr 7th, 2024 06:48AM
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories, with an additional eight patents pending.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
|
Open
|
Multifocal Contact Lenses
|
Open
|
10745 Westside Way
|
Alpharetta
|
Georgia
|
US
|
30009
|
|
Visioneering Technologies
|
|
|
|
asx:vti
|
10193401
|
Apr 6th, 2024 12:00AM
|
Visioneering Technologies Inc.
|
1.2K
|
29.00
|
Open
|
|
Apr 6th, 2024 06:29AM
|
Apr 6th, 2024 06:29AM
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories, with an additional eight patents pending.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
|
Open
|
Multifocal Contact Lenses
|
Open
|
10745 Westside Way
|
Alpharetta
|
Georgia
|
US
|
30009
|
|
Visioneering Technologies
|
|
|
|
asx:vti
|
10193401
|
Apr 5th, 2024 12:00AM
|
Visioneering Technologies Inc.
|
1.2K
|
29.00
|
Open
|
|
Apr 5th, 2024 09:09AM
|
Apr 5th, 2024 09:09AM
|
Visioneering Technologies, Inc., headquartered in Alpharetta, Georgia, is an innovative new company that is dedicated to redefining vision. With a portfolio of technologies to address eye care issues such as presbyopia in adults and myopia correction in children, the company uses creative and differentiated design approaches to develop products that will ultimately enhance practitioner and patient experiences.
VTI holds fourteen issued patents worldwide that address the need for a treatment for presbyopia in the underdeveloped on-eye/in-eye categories, with an additional eight patents pending.
VTI brings together clinical, marketing, engineering, manufacturing and regulatory leaders from today's top vision care businesses. Together, these industry veterans bring the best thinking in eye care to design and bring to market new solutions for presbyopia, myopia and astigmatism.
|
Open
|
Multifocal Contact Lenses
|
Open
|
10745 Westside Way
|
Alpharetta
|
Georgia
|
US
|
30009
|
|
Visioneering Technologies
|
|
|